Moreover, the expression of GSK3β/β-catenin was increased in the heart tissue of the MI model in vivo; however, this change was inhibited by high doses of the ACP5 inhibitor (Fig. 5I-L). This evidence concerns the gene ACP5 and myocardial infarction.